Neo-MASCT Immunotherapy for Advanced NSCLC.
NCT03205930
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
NSCLC Stage IV
Interventions
BIOLOGICAL:
Neo-MASCT
Sponsor
The First People's Hospital of Lianyungang
Collaborators
[object Object]